The role of natural killer cells in tumor control-effectors and regulators of adaptive immunity

Springer Seminars in Immunopathology

Volumn 27, Issue 1, 2005, Pages 49-64

  Wallace, Morgan E ^a   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Cytokine; Cytotoxicity; Dendritic cells; Immunosurveillance; Immunotherapy

Indexed keywords

BETA INTERFERON; CD16 ANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGIC AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER THERAPY; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL SURFACE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR REJECTION;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEOPLASMS;

EID: 21344457276     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-004-0195-x     Document Type: Review

References (115)

1. + subset. J Allergy Clin Immunol 85:453
2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245
3. Bauer S, Groh V, Wu J, et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727
4. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med, 184:1845
5. Borrego F, Kabat J, Kim DK, et al (2002) Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 38:637
6. Brady J, Hayakawa Y, Smyth MJ, et al (2004) IL-21 induces the functional maturation of murine NK cells. J Immunol 172:2048
7. Buentke E, Heffler LC, Wilson JL, et al (2002) Natural killer and dendritic cell contact in lesional atopic dermatitis skin - Malassezia- influenced cell interaction. J Invest Dermatol 119:850
8. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166:6477
9. Cerwenka A, Baron JL, Lanier LL (2001) Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 98:11521
10. Cerwenka A, Lanier LL (2001) Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 181:158
11. Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41
12. Chalifour A, Jeannin P, Gauchat JF, et al (2004) Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood 104:1778
13. Colucci F, Caligiuri MA, Di Santo JP (2003) What does it take to make a natural killer? Nat Rev Immunol 3:413
14. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633
15. Cooper MA, Fehniger TA, Fuchs A, et al (2004) NK cell and DC interactions. Trends Immunol 25:47
16. Cretney E, Takeda K, Yagita H, et al (2002) Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168:1356
17. Cui Z, Willingham MC, Hicks AM, et al (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci USA 100:6682
18. Davis JE, Smyth MJ, Trapani JA (2001) Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol 31:39
19. Della Chiesa M, Vitale M, Carlomagno S, et al (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33:1657
20. Diefenbach A, Jensen ER, Jamieson AM, et al (2001) Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165
21. Diefenbach A, Tomasello E, Lucas M, et al (2002) Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 3:1142
22. Dokun AO, Kim S, Smith HR, et al (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2:951
23. + DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33:827
24. Ferlazzo G, Morandi B, D'Agostino A, et al (2003) The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33:306
25. Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333
26. Ferlazzo G, Semino C, Melioli G (2001) HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 76:37
27. Ferlazzo G, Thomas D, Lin SL, et al (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172:1455
28. Ferlazzo G, Tsang ML, Moretta L, et al (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343
29. Fernandez NC, Lozier A, Flament C, et al (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405
30. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5:1249
31. Gao Y, Yang W, Pan M, et al (2003) Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198:433
32. Garni-Wagner BA, Purohit A, Mathew PA, et al (1993) A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 151:60
33. Geldhof AB, Raes G, Bakkus M, et al (1995) Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res 55:2730
34. Gerosa F, Baldani-Guerra B, Nisii C, et al (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327
35. Granucci F, Vizzardelli C, Pavelka N, et al (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2:882
36. Granucci F, Zanoni I, Pavelka N, et al (2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200:287
37. Griffith TS, Chin WA, Jackson GC, et al (1998) Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833
38. Haliotis T, Ball JK, Dexter D, et al (1985) Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice. Int J Cancer 35:505
39. Hashimoto W, Tanaka F, Robbins PD, et al (2003) Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18. Int J Cancer 103:508
40. Hayakawa Y, Kelly JM, Westwood JA, et al (2002) Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perform. J Immunol 169:5377
41. Hayakawa Y, Screpanti V, Yagita H, et al (2004) NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172:123
42. Hayakawa Y, Takeda K, Yagita H, et al (2002) IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide. Blood 100:1728
43. Houchins JP, Yabe T, McSherry C, et al (1991) DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173:1017
44. Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13:95
45. Irmler M, Thome M, Hahne M, et al (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190
46. Kadowaki N, Ho S, Antonenko S, et al (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194:863
47. Karre K, Ljunggren HG, Piontek G, et al (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675
48. Kasaian MT, Whitters MJ, Carter LL, et al (2002) IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16:559
49. Kelly JM, Darcy PK, Markby JL, et al (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3:83
50. Kelly JM, Takeda K, Darcy PK, et al (2002) A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 168:4472
51. Kennedy MK, Glaccum M, Brown SN, et al (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191:771
52. Kiessling R, Petranyi G, Klein G, et al (1975) Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer 15:933
53. Kim S, Iizuka K, Kang HS, et al (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3:523
54. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359
55. Lanier LL, Le AM, Civin CI, et al (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480
56. Lian RH, Kumar V (2002) Murine natural killer cell progenitors and their requirements for development. Semin Immunol 14:453
57. Liao NS, Bix M, Zijlstra M, et al (1991) MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199
58. Ljunggren HG, Karre K (1985) Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162:1745
59. Loza MJ, Perussia B (2001) Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2:917
60. 59a. Martin-Fontecha A, Thomsen LL, Brett S et al. (2004) Induced recruitment of NK cells to lymph nodes provides IFN-γ for Th1 priming. Nat Immunol 5:1260
61. McQueen KL, Parham P (2002) Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14:615
62. Medzhitov R, Janeway CA Jr (1998) Innate immune recognition and control of adaptive immune responses. Semin Immunol 10:351
63. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255
64. Mocikat R, Braumuller H, Gumy A, et al (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19:561
65. + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173:900
66. Moser M (2003) Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 19:5
67. O'Hanlon LH (2004) Natural born killers: NK cells drafted into the cancer fight. J Natl Cancer Inst 96:651
68. Ogasawara K, Yoshinaga SK, Lanier LL (2002) Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J Immunol 169: 3676
69. Pawelec G, Da Silva P, Max H, et al (1995) Relative roles of natural killer- and T cell-mediated antileukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma 18:471
70. Peritt D, Robertson S, Gri G, et al (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161:5821
71. Piccioli D, Sbrana S, Melandri E, et al (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195:335
72. Reis e Sousa C, Diebold SD, Edwards AD, et al (2003) Regulation of dendritic cell function by microbial stimuli. Pathol Biol (Paris) 51:67
73. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71:173
74. Rosenberg SA (2000) Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer. Cancer J Sci Am 6 Suppl 1: S2
75. Roth C, Carlyle JR, Takizawa H, et al (2000) Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class IMHC. Immunity 13:143
76. Ruggeri L, Capanni M, Urbani E, et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097
77. Sauter B, Albert ML, Francisco L, et al (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423
78. Screpanti V, Wallin RP, Ljunggren HG, et al (2001) A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol 167:2068
79. Seya T, Akazawa T, Uehori J, et al (2003) Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res 23:4369
80. Shortman K, Liu YJ (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151
81. Silla LM, Whiteside TL, Ball ED (1995) The role of natural killer cells in the treatment of chronic myeloid leukemia. J Hematother 4:269
82. Sivakumar PV, Foster DC, Clegg CH (2004) Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses. Immunology 112:177
83. Sivori S, Falco M, Della Chiesa M, et al (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101:10116
84. Smyth MJ, Cretney E, Takeda K, et al (2001) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 193:661
85. Smyth MJ, Crowe NY, Godfrey DI (2001) NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol 13:459
86. Smyth MJ, Hayakawa Y, Takeda K, et al (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2:850
87. Smyth MJ, Street SE, Trapani JA (2003) Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 171:515
88. Smyth MJ, Takeda K, Hayakawa Y, et al (2003) Nature's TRAIL - on a path to cancer immunotherapy. Immunity 18:1
89. Smyth MJ, Taniguchi M, Street SE (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165:2665
90. Smyth MJ, Thia KY, Cretney E, et al (1999) Perform is a major contributor to NK cell control of tumor metastasis. J Immunol 162:6658
91. Smyth MJ, Thia KY, Street SE, et al (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med 191:661
92. Smyth MJ, Thia KY, Street SE, et al (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192:755
93. Smyth MJ, Trapani JA (1995) Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202
94. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al (1999) Perform gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957
95. Street SE, Cretney E, Smyth MJ (2001) Perform and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97:192
96. Street SE, Hayakawa Y, Zhan Y, et al (2004) Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells. J Exp Med 199:879
97. Takeda K, Hayakawa Y, Smyth MJ, et al (2001) Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7:94
98. Takeda K, Smyth MJ, Cretney E, et al (2002) Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 195:161
99. Takei F, McQueen KL, Maeda M, et al (2001) Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol Rev 181:90
100. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735
101. Trinchieri G (1998) Immunobiology of interleukin-12. Immunol Res 17:269
102. Van den Broek MF, Kagi D, Zinkernagel RM, et al (1995) Perform dependence of natural killer cell-mediated tumor control in vivo. Eur J Immunol 25:3514
103. Waldmann TA, Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19
104. Whiteside TL, Herberman RB (1995) The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7:704
105. Whiteside TL, Vujanovic NL and Herberman RB (1998) Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 230:221
106. +, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 186:1609
107. Wilson JL, Heffler LC, Charo J, et al (1999) Targeting of human dendritic cells by autologous NK cells. J Immunol 163:6365
108. Wilson MJ, Torkar M, Haude A, et al (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 97:4778
109. Wooldridge JE, Weiner GJ (2003) CpG DNA and cancer immunotherapy: orchestrating the antitumor immune response. Curr Opin Oncol 15:440
110. Wu J, Lanier LL (2003) Natural killer cells and cancer. Adv Cancer Res 90:127
111. Yasumura S, Lin WC, Hirabayashi H, et al (1994) Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells. Cancer Res 54:3808
112. Yokoyama WM, Daniels BF, Seaman WE, et al (1995) A family of murine NK cell receptors specific for target cell MHC class I molecules. Semin Immunol 7:89
113. Yokoyama WM, Plougastel BF (2003) Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3:304
114. Yuan D, Koh CY, Wilder JA (1994) Interactions between B lymphocytes and NK cells. FASEB J, 8:1012
115. Zitvogel L (2002) Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195:F9